AstraZeneca AB’s $790 Million Divestment Agreements

Paolo Bossi Europe, Europe Legal Chronicle

Greenberg Traurig LLP represented AstraZeneca AB on its agreement with Grünenthal to divest the European rights to Nexium for an upfront payment of USD700 million with…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Paolo Bossi

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here